Cargando…

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma

BACKGROUND: The decrease in peripheral blood lymphocytes induced by radiation lessens the antitumour effect of the immune response, which might cause immunosuppression. We aimed to investigate the correlation between the decrease in peripheral blood lymphocytes during radiotherapy (RT) and the splee...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Zhao, Qianqian, Deng, Weiye, Lu, Jie, Xu, Xiaoqing, Wang, Renben, Li, Xia, Yue, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450236/
https://www.ncbi.nlm.nih.gov/pubmed/28558844
http://dx.doi.org/10.1186/s13014-017-0824-x
_version_ 1783239928468996096
author Liu, Jing
Zhao, Qianqian
Deng, Weiye
Lu, Jie
Xu, Xiaoqing
Wang, Renben
Li, Xia
Yue, Jinbo
author_facet Liu, Jing
Zhao, Qianqian
Deng, Weiye
Lu, Jie
Xu, Xiaoqing
Wang, Renben
Li, Xia
Yue, Jinbo
author_sort Liu, Jing
collection PubMed
description BACKGROUND: The decrease in peripheral blood lymphocytes induced by radiation lessens the antitumour effect of the immune response, which might cause immunosuppression. We aimed to investigate the correlation between the decrease in peripheral blood lymphocytes during radiotherapy (RT) and the spleen irradiation dose in patients with hepatocellular carcinoma (HCC). METHODS: The subjects were 59 patients with HCC who had received RT from 2005 to 2014. The Min ALC (minimum value of absolute counts for peripheral blood lymphocytes) was collected from the routine workup for each patient prior to RT and weekly during RT. Spleen dose-volume variables, including the percentage of the organ volume receiving ≥ n Gy (V(n)) and the mean spleen dose (MSD), were calculated using Eclipse treatment planning. Potential associations between dosimetric variables and the Min ALC were assessed by multiple linear regression analysis. RESULTS: Peripheral lymphocytes decreased during RT (P < 0.001). The Min ALC correlated with the MSD (P = 0.005), spleen V(5) (P = 0.001), spleen V(25) (P = 0.026) and spleen V(30) (P = 0.018). Controlling for the Karnofsky performance status (KPS), sex, age, Child-Pugh grade, total dose and tumour stage, a multiple linear regression model with bootstrap analysis of 1000 replicates showed that only the spleen V(5) was correlated with the decrease in the Min ALC (P < 0.05). According to the receiver-operating characteristic (ROC) curve analysis, the predictive cutoff values of the MSD, V(5), V(25) and V(30) of the spleen for the Min ALC were 227.72 cGy, 17.84, 0.98 and 0.42%, respectively (P = 0.002, P = 0.004, P = 0.007 and P = 0.002, respectively). Furthermore, an MSD ≥ 227.72 cGy (OR = 14.39; 95% CI, 12.18 to 16.60) and V(5) (OR = 7.99; 95% CI, 6.91 to 9.07) of the spleen significantly predicted the Min ALC. CONCLUSIONS: Higher spleen irradiation doses were significantly correlated with lower Min ALC during RT for HCC. V(5) should be limited in clinical practice. Maximum sparing for spleen irradiation during RT is recommended to preserve peripheral blood lymphocytes, which may decrease immunosuppression.
format Online
Article
Text
id pubmed-5450236
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54502362017-06-01 Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma Liu, Jing Zhao, Qianqian Deng, Weiye Lu, Jie Xu, Xiaoqing Wang, Renben Li, Xia Yue, Jinbo Radiat Oncol Research BACKGROUND: The decrease in peripheral blood lymphocytes induced by radiation lessens the antitumour effect of the immune response, which might cause immunosuppression. We aimed to investigate the correlation between the decrease in peripheral blood lymphocytes during radiotherapy (RT) and the spleen irradiation dose in patients with hepatocellular carcinoma (HCC). METHODS: The subjects were 59 patients with HCC who had received RT from 2005 to 2014. The Min ALC (minimum value of absolute counts for peripheral blood lymphocytes) was collected from the routine workup for each patient prior to RT and weekly during RT. Spleen dose-volume variables, including the percentage of the organ volume receiving ≥ n Gy (V(n)) and the mean spleen dose (MSD), were calculated using Eclipse treatment planning. Potential associations between dosimetric variables and the Min ALC were assessed by multiple linear regression analysis. RESULTS: Peripheral lymphocytes decreased during RT (P < 0.001). The Min ALC correlated with the MSD (P = 0.005), spleen V(5) (P = 0.001), spleen V(25) (P = 0.026) and spleen V(30) (P = 0.018). Controlling for the Karnofsky performance status (KPS), sex, age, Child-Pugh grade, total dose and tumour stage, a multiple linear regression model with bootstrap analysis of 1000 replicates showed that only the spleen V(5) was correlated with the decrease in the Min ALC (P < 0.05). According to the receiver-operating characteristic (ROC) curve analysis, the predictive cutoff values of the MSD, V(5), V(25) and V(30) of the spleen for the Min ALC were 227.72 cGy, 17.84, 0.98 and 0.42%, respectively (P = 0.002, P = 0.004, P = 0.007 and P = 0.002, respectively). Furthermore, an MSD ≥ 227.72 cGy (OR = 14.39; 95% CI, 12.18 to 16.60) and V(5) (OR = 7.99; 95% CI, 6.91 to 9.07) of the spleen significantly predicted the Min ALC. CONCLUSIONS: Higher spleen irradiation doses were significantly correlated with lower Min ALC during RT for HCC. V(5) should be limited in clinical practice. Maximum sparing for spleen irradiation during RT is recommended to preserve peripheral blood lymphocytes, which may decrease immunosuppression. BioMed Central 2017-05-30 /pmc/articles/PMC5450236/ /pubmed/28558844 http://dx.doi.org/10.1186/s13014-017-0824-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Jing
Zhao, Qianqian
Deng, Weiye
Lu, Jie
Xu, Xiaoqing
Wang, Renben
Li, Xia
Yue, Jinbo
Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title_full Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title_fullStr Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title_full_unstemmed Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title_short Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
title_sort radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450236/
https://www.ncbi.nlm.nih.gov/pubmed/28558844
http://dx.doi.org/10.1186/s13014-017-0824-x
work_keys_str_mv AT liujing radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT zhaoqianqian radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT dengweiye radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT lujie radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT xuxiaoqing radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT wangrenben radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT lixia radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma
AT yuejinbo radiationrelatedlymphopeniaisassociatedwithspleenirradiationdoseduringradiotherapyinpatientswithhepatocellularcarcinoma